RxSight, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
RxSight, Inc. (RXST) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-05-06
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was -$9.00K, a 212.50% decline year-over-year.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $9.00K, a 64.00% decline year-over-year.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $49.00K, a 70.30% decline from fiscal 2023.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $165.00K, a 19.57% increase from fiscal 2022.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $138.00K, a 961.54% increase from fiscal 2021.
- RxSight, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $13.00K, a 91.82% decline from fiscal 2020.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$9.00K derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $8.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $8.00K derived: sum of 3 quarters · filed 2026-05-06 | $16.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-06 | $17.00K derived: sum of 2 quarters · filed 2026-05-06 | $25.00K derived: sum of 3 quarters · filed 2026-05-06 | $33.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $16.00K derived: sum of 2 quarters · filed 2025-11-05 | $24.00K derived: sum of 3 quarters · filed 2025-11-05 | $49.00K 10-K · filed 2025-02-25 |
| 2024-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $16.00K derived: sum of 2 quarters · filed 2025-11-05 | $41.00K 10-Q · filed 2025-11-05 | $74.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $33.00K 10-Q · filed 2025-08-07 | $66.00K derived: sum of 3 quarters · filed 2025-08-07 | $113.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $25.00K 10-Q · filed 2025-05-07 | $58.00K derived: sum of 2 quarters · filed 2025-05-07 | $105.00K derived: sum of 3 quarters · filed 2025-05-07 | $146.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $80.00K derived: sum of 2 quarters · filed 2025-02-25 | $121.00K derived: sum of 3 quarters · filed 2025-02-25 | $165.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $88.00K derived: sum of 2 quarters · filed 2024-11-07 | $132.00K 10-Q · filed 2024-11-07 | $175.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $85.00K 10-Q · filed 2024-08-05 | $128.00K derived: sum of 3 quarters · filed 2025-02-25 | $167.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-06 | $87.00K derived: sum of 2 quarters · filed 2025-02-25 | $126.00K derived: sum of 3 quarters · filed 2025-02-25 | $163.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $82.00K derived: sum of 2 quarters · filed 2025-02-25 | $119.00K derived: sum of 3 quarters · filed 2025-02-25 | $138.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $76.00K derived: sum of 2 quarters · filed 2023-11-09 | $95.00K 10-Q · filed 2023-11-09 | $89.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $56.00K 10-Q · filed 2023-08-07 | $50.00K derived: sum of 3 quarters · filed 2023-08-07 | $54.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-09 | $13.00K derived: sum of 2 quarters · filed 2023-05-09 | $17.00K derived: sum of 3 quarters · filed 2023-05-09 | $24.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$2.00K derived: sum of 2 quarters · filed 2023-03-06 | $5.00K derived: sum of 3 quarters · filed 2023-03-06 | $13.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $11.00K derived: sum of 2 quarters · filed 2022-11-07 | $19.00K 10-Q · filed 2022-11-07 | $27.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $15.00K 10-Q · filed 2022-08-08 | $23.00K derived: sum of 3 quarters · filed 2022-08-08 | $68.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $8.00K 10-Q · filed 2022-05-05 | $16.00K derived: sum of 2 quarters · filed 2022-05-05 | $61.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $53.00K derived: sum of 2 quarters · filed 2022-03-08 | $159.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $151.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $106.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |